Viemed acquires stake in Verustat
By HME News Staff
Updated 9:37 AM CST, Mon December 21, 2020
LAFAYETTE, La. – Viemed Healthcare has acquired a 5% interest in Verustat for $600,000, giving it a platform to enter the remote monitoring space.
Viemed will use Verustat’s RPM solution in conjunction with its own proprietary patient engagement platform (PEP), which has shown to improve patient compliance, along with labor and workflow efficiencies, according to preliminary data.
“The pandemic has revealed a great demand by physicians and patients to safely use technology to provide patient care inside of the home,” said Casey Hoyt, Viemed CEO. “We are excited to be partnering with Verustat in the RPM space, as their unique solution will fit well with our physician network.”
Verustat, which recently became a vendor partner with VGM & Associates, pays providers management fees for introducing their company and its RPM solution to physicians, and helping the company facilitate and manage those relationships.
Viemed expects the RPM platform to add incremental revenue in 2021, while driving new adjacencies, Hoyt says.
“While the RPM space is new, it complements our mission of interacting more frequently with chronically ill patients across multiple disease states, even beyond respiratory illnesses,” he said.
Comments